Co-Diagnostics has entered an agreement with its joint venture partner CoSara Diagnostics to expand its commercial and ...

Rapid near-point-of-care molecular tests using tongue swabs can help end TB, enabling diagnosis and treatment to begin within ...

Co-Diagnostics inks agreement with CoSara Diagnostics to expand commercial and distribution territory across South Asia: Salt Lake City Monday, March 23, 2026, 12:00 Hrs [IST] Co- ...

Co-Diagnostics Inc. on Friday signed an agreement for CoSara Diagnostics Pvt. Ltd, to expand its commercial and distribution ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...

A new HRM PCR approach can track the spread of leishmaniasis, a parasitic disease affecting both animals and humans.

A genetic analysis finds that nearly 47.42% of corvina samples collected from various markets contain shark meat ...

-- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...

ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based ...

QUANTDx Samples with "Normalized" Viral Loads for Validating HPV Assays MISSISSAUGA, ON / ACCESS Newswire / March 17, 2026 / ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...